UrtesteS.A.Active

Research and experimental development on biotechnology

KRS: 0000886944 NIP: 5833355988 REGON: 38339466300000

Overview

Registry date
2021-03-02
Share capital
$38,078.58
Activity description

Urteste is developing the world's first method for detecting multiple cancers from a single urine sample. This early cancer detection technology aims to enable effective treatment by identifying the disease at an early stage.

Registered address
Ul. Starodworska 1, 80-137 Gdańsk, Poland
Website
urteste.comWebsite active
Electronic delivery address
AE:PL-66021-48593-SJJTT-14

Industry

NameCode
Research and experimental development on biotechnology
72.11.Z
Other research and experimental development on natural sciences and engineering
72.19.Z
Other professional, scientific and technical activities not elsewhere classified
74.90.Z
Other technical testing and analysis
71.20.B

Accounts

Registered as a VAT taxpayer on 2019-06-08.Active

Authorized Representatives

Ownership

Competitors

NameRevenueWebsite
UveraS.A.$155,384.29uvera.eu
PellicarnosS.A.$135,043.43pellicarnos.com
IntelliseqS.A.$111,419.60intelliseq.pl
WPD PharmaceuticalsS.A.$87,561.70wpdpharmaceuticals.pl/contact/wpdsa/
DigitmedS.A.$64,087.41digitmed.pl
InventroS.A.$12,176.61inventro.co
ArthecS.A.$10,911.16arthec.eu
Oncotherics PolandS.A.$7,565.33oncotherics.com
4cell TherapiesS.A.$838.644celltherapies.com
Ncage TherapeuticsS.A.$29.14ncage.org

FAQ

Last updated: 2025-12-14